Aldesleukin Withdrawn Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00935558Dendritic Cell Based Therapy for Breast Cancer Patients